Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLEAR: Beclomethasone Dipropionate in Acute Rhinosinusitis
NCT01691677Phase 3Completed
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Start
- Jan 2013
- Primary completion
- Jan 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of beclomethasone dipropionate in acute rhinosinusitis (ARS), sponsored by Chiesi Farmaceutici S.p.A.. Started Jan 2013; status: completed.
02
Drugs
beclomethasone dipropionate
03
Conditions
acute rhinosinusitis (ARS)
Beyond the preview
Go deeper on NCT01691677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01691677.